BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 38031348)

  • 1. Probiotics intervention in colorectal cancer: From traditional approaches to novel strategies.
    Ha S; Zhang X; Yu J
    Chin Med J (Engl); 2024 Jan; 137(1):8-20. PubMed ID: 38031348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotics and postbiotics in colorectal cancer: Prevention and complementary therapy.
    Kvakova M; Kamlarova A; Stofilova J; Benetinova V; Bertkova I
    World J Gastroenterol; 2022 Jul; 28(27):3370-3382. PubMed ID: 36158273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer.
    Fong W; Li Q; Yu J
    Oncogene; 2020 Jun; 39(26):4925-4943. PubMed ID: 32514151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer?
    Azcárate-Peril MA; Sikes M; Bruno-Bárcena JM
    Am J Physiol Gastrointest Liver Physiol; 2011 Sep; 301(3):G401-24. PubMed ID: 21700901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Crucial Roles of Diet, Microbiota, and Postbiotics in Colorectal Cancer.
    Kuru-Yaşar R; Üstün-Aytekin Ö
    Curr Nutr Rep; 2024 Jun; 13(2):126-151. PubMed ID: 38483752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota modulation: a tool for the management of colorectal cancer.
    Wang Y; Li H
    J Transl Med; 2022 Apr; 20(1):178. PubMed ID: 35449107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postbiotics versus probiotics in early-onset colorectal cancer.
    Feizi H; Plotnikov A; Rezaee MA; Ganbarov K; Kamounah FS; Nikitin S; Kadkhoda H; Gholizadeh P; Pagliano P; Kafil HS
    Crit Rev Food Sci Nutr; 2024; 64(11):3573-3582. PubMed ID: 36250549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of gut microbiota and probiotics in preventing, treating, and boosting the immune system in colorectal cancer.
    Masheghati F; Asgharzadeh MR; Jafari A; Masoudi N; Maleki-Kakelar H
    Life Sci; 2024 May; 344():122529. PubMed ID: 38490297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotics, prebiotics and colorectal cancer prevention.
    Ambalam P; Raman M; Purama RK; Doble M
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):119-31. PubMed ID: 27048903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intervention on gut microbiota may change the strategy for management of colorectal cancer.
    Taghinezhad-S S; Mohseni AH; Fu X
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1508-1517. PubMed ID: 33295040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of probiotics in the prevention and treatment of colorectal cancer.
    Eslami M; Yousefi B; Kokhaei P; Hemati M; Nejad ZR; Arabkari V; Namdar A
    J Cell Physiol; 2019 Aug; 234(10):17127-17143. PubMed ID: 30912128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota and colorectal cancer: insights into pathogenesis for novel therapeutic strategies.
    Kang Y; Pan W; Cai Y
    Z Gastroenterol; 2017 Sep; 55(9):872-880. PubMed ID: 29186641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implication of gut microbes and its metabolites in colorectal cancer.
    Kumar A; Ali A; Kapardar RK; Dar GM; Nimisha ; Apurva ; Sharma AK; Verma R; Sattar RSA; Ahmad E; Mahajan B; Saluja SS
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):441-465. PubMed ID: 36572792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of postbiotics in colorectal cancer prevention and treatment.
    Rad AH; Aghebati-Maleki L; Kafil HS; Abbasi A
    Crit Rev Food Sci Nutr; 2021; 61(11):1787-1803. PubMed ID: 32410512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for the treatment of colorectal cancer caused by gut microbiota.
    de Souza JB; Brelaz-de-Castro MCA; Cavalcanti IMF
    Life Sci; 2022 Feb; 290():120202. PubMed ID: 34896161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutraceuticals in colorectal cancer: A mechanistic approach.
    Rossi M; Mirbagheri SEYEDS; Keshavarzian A; Bishehsari F
    Eur J Pharmacol; 2018 Aug; 833():396-402. PubMed ID: 29935172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between gut microbiota and colorectal cancer: Probiotics as a potential strategy for prevention.
    Lee SY; Lee DY; Kang JH; Kim JH; Jeong JW; Kim HW; Oh DH; Yoon SH; Hur SJ
    Food Res Int; 2022 Jun; 156():111327. PubMed ID: 35651078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal microbiota and colorectal cancer: a new aspect of research.
    Koliarakis I; Psaroulaki A; Nikolouzakis TK; Kokkinakis M; Sgantzos MN; Goulielmos G; Androutsopoulos VP; Tsatsakis A; Tsiaoussis J
    J BUON; 2018; 23(5):1216-1234. PubMed ID: 30512251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Protective Role of Probiotics against Colorectal Cancer.
    Ding S; Hu C; Fang J; Liu G
    Oxid Med Cell Longev; 2020; 2020():8884583. PubMed ID: 33488940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucins, gut microbiota, and postbiotics role in colorectal cancer.
    Pothuraju R; Chaudhary S; Rachagani S; Kaur S; Roy HK; Bouvet M; Batra SK
    Gut Microbes; 2021; 13(1):1974795. PubMed ID: 34586012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.